Download PDF
Thromb Haemost 1998; 80(02): 349-350
DOI: 10.1055/s-0037-1615206
Letters to the Editor
Schattauer GmbH

Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants (LA)

Authors

  • Armando Tripodi

    1   Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, University and IRCCS Maggiore Hospital, Milano, Italy

  • Pier Mannuccio Mannucci

    1   Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Institute of Internal Medicine, University and IRCCS Maggiore Hospital, Milano, Italy
Further Information

Publication History

Received 23 January 1998

Accepted after revision 02 April 1998

Publication Date:
08 December 2017 (online)

   Permissions and Reprints
Preview

 

 

  • References

  • 1 Moll S, Ortel TL. Monitoring warfarin therapy in patients with lupus anticoagulants.. Ann Int Med 1998; 127: 177-85.
    PubMedSearch in Google Scholar
  • 2 Lawrie AS, Purdy G, Mackie IJ, Machin SJ. Monitoring of oral anticoagulant therapy in lupus anticoagulant positive patients with the anti-phospholipid syndrome.. Brit J Haematol 1998; 98: 887-92.
    PubMedSearch in Google Scholar
  • 3 Della Valle P, Crippa L, Safa O, Tomassini L, Pattarini E, Vigano’-D’Angelo S, Sabbadini MG, D’Angelo A. Potential failure on the International Normalized Ratio (INR) system in the monitoring of oral anticoagulation in patients with lupus anticoagulants.. Ann Med Interne 1996; 147 (Suppl. 01) 10-4.
    PubMedSearch in Google Scholar
  • 4 WHO Expert Committee on Biological Standardization.. Guidelines for thromboplastin and plasma used to control oral anticoagulant therapy.. To be published. Technical Report Series 1998.
    PubMed